Vergleich

Hyaluronic acid (sodium) Europäischer Partner

ArtNr HY-B0633-25g
Hersteller MedChem Express
CAS-Nr. 9067-32-7
Menge 25 g
Quantity options 100 mg 10 g 10 mMx1 mL 10 mg 1 g 200 mg 25 g 500 mg 50 mg 5 g
Specific against other
Purity 98.0
Smiles CCC1[C@@H](O)[C@@H](O)O[C@@H](O[C@H]2[C@H](C(O[Na])=O)OC(OC)[C@@H](O)[C@@H]2O)[C@@H]1NC(C)=O.[n]
Alias Sodium hyaluronate
Versandbedingung Raumtemperatur
Lieferbar
Manufacturer - Type
Natural Products
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
Akt; Bacterial; Endogenous Metabolite; PI3K
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
1500 (kDa)
Product Description
Hyaluronic acid sodium (Sodium hyaluronate) is a biopolymer composed of repeating units of disaccharides with various applications. Hyaluronic acid sodium is a major component of the extracellular matrix (ECM). Hyaluronic acid sodium is synthesized at the plasma membrane. Increased hyaluronic acid sodium levels are associated with tumor cell growth, adhesion, migration, invasion and angiogenesis in digestive cancers. Hyaluronic acid sodium participates in tissue remodeling and rapid cell proliferation in some physiological processes including embryonic morphogenesis and wound-healing. Hyaluronic acid sodium activates the PI3K-Akt signaling. Hyaluronic acid sodium acts as a regulator of cancer-associated lymphangiogenesis. Hyaluronic acid sodium also enhances cell invasion and angiogenesis by promoting proteolytic MMP-9 binding to cell surface or stimulating MMP-9 binding to cell surface. Hyaluronic acid sodium can be used as drug delivery for sodium butyrate to improve the anti-proliferative activity on breast cancer cell line. Hyaluronic acid sodium can be studied in joint diseases, wound healing and cancer[1][2][3][4][5].
Manufacturer - Research Area
Cancer; Inflammation/Immunology
Solubility
DMSO : < 1 mg/mL|H2O : 3.33 mg/mL (ultrasonic)
Manufacturer - Pathway
Anti-infection; Metabolic Enzyme/Protease; PI3K/Akt/mTOR
Clinical information
Launched
Isoform
Human Endogenous Metabolite

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 25 g
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen